70
Participants
Start Date
January 13, 2021
Primary Completion Date
August 2, 2022
Study Completion Date
August 18, 2022
Nintedanib
Nintedanib
Inje University Ilsan Paik Hospital, Gyeonggi-do
Seoul National University Bundang Hospital, Gyeonggi-do
Chungbuk national University Hospital, Chungcheongbuk-do
SoonChunHyang University Cheonan Hospital, Chungcheongnam-do
Keimyung University Dongsan Hospital, Daegu
Ulsan University Hospital, Ulsan
Dong-A University Hospital, Busan
Pusan National University Yangsan Hospital, Gyeongsangnam-do
Gyeongsang National University Changwon Hospital, Gyeongsangnam-do
Wonkwang Univertisy Hospital, Jeollabuk-do
Jeonbuk National University Hospital, Jeollabuk-do
Chonnam National University Hospital, Gwangju
Jeju National University Hospital, Jeju-do
Myongji Hospital, Gyeonggi-do
KyungHee University Medical Center, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Hanyang University Medical Center, Seoul
Kyung Hee University Hospital at Gangdong, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Catholic University of Korea Seoul St. Mary's Hospital, Seoul
Lead Sponsor
Boehringer Ingelheim
INDUSTRY